Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luanne Bershaw

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pharmacoepidemiology and Drug Safety|December 16, 2014
Factors affecting time to maintenance dose in patients initiating warfarinBrian S Finkelman, Benjamin French, Luanne Bershaw, et al.
Pharmacoepidemiology and Drug Safety|July 27, 2016
Predicting prolonged dose titration in patients starting warfarinBrian S Finkelman, Benjamin French, Luanne Bershaw, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Immunologic perturbations in severe COVID-19/SARS-CoV-2 infectionLeticia Kuri-Cervantes, M Betina Pampena, Wenzhao Meng, et al.
Science Immunology|July 17, 2020
Comprehensive mapping of immune perturbations associated with severe COVID-19Leticia Kuri-Cervantes, M Betina Pampena, Wenzhao Meng, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pharmacoepidemiology and Drug Safety|December 16, 2014
Factors affecting time to maintenance dose in patients initiating warfarinBrian S Finkelman, Benjamin French, Luanne Bershaw, et al.
Pharmacoepidemiology and Drug Safety|July 27, 2016
Predicting prolonged dose titration in patients starting warfarinBrian S Finkelman, Benjamin French, Luanne Bershaw, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Immunologic perturbations in severe COVID-19/SARS-CoV-2 infectionLeticia Kuri-Cervantes, M Betina Pampena, Wenzhao Meng, et al.
Science Immunology|July 17, 2020
Comprehensive mapping of immune perturbations associated with severe COVID-19Leticia Kuri-Cervantes, M Betina Pampena, Wenzhao Meng, et al.
Pageof 1